Three Scientists Win Nobel Medicine Prize for Brain Light Switch

The 2026 Nobel Medicine Prize was awarded Monday to Karl Deisseroth, Peter Hegemann and Georg Nagel for discoveries behind optogenetics, a method that lets scientists switch individual nerve cells on and off with light in a living brain. Deisseroth, 54, is an American researcher at Stanford University; Hegemann, 71, works at Humboldt University in Berlin; and Nagel, 73, is at the University of Wurzburg, according to the Nobel Assembly at Sweden's Karolinska Institute, which announced the prize in Stockholm. The committee said the method is now used in laboratories around the world to reveal the brain's mysteries.

Optogenetics works like a light-sensitive switch planted inside nerve cells. Scientists insert a protein borrowed from algae into a chosen set of neurons, then shine pulses of blue light to make those cells fire, or a different wavelength to keep them quiet. That lets a researcher test which exact circuit carries a memory, steadies a hand, or tips a mood. Before this tool, probing a living brain meant blunt instruments; now labs can flip one circuit at a time and watch what changes. The Nobel Medicine Prize recognizes a technique that moved that kind of experiment from impossible to routine, and its precision matters for conditions such as Parkinson's, epilepsy and depression, where neurons fire at the wrong time.

From pond algae to the human brain

The discovery started with a question about pond life. Hegemann was studying how a single-celled green alga swims toward light when he and Nagel found the protein that made it possible: channelrhodopsin, which swings open a channel in the cell's membrane under blue light so charged particles rush in and create an electrical impulse. Deisseroth then took the gene for that protein and got it working in the neurons of living mice, turning the algae's trick into a remote control for brain cells. The Nobel Assembly cited the trio for discoveries concerning light-gated ion channels and optogenetics, calling the work the start of a new era in neuroscience. Years of follow-up turned the method into standard lab equipment, and by switching cells on and off in sequence, scientists can now trace the circuits behind sleep, appetite, fear and reward.

A late-night phone call and a terrace in the sun

Deisseroth learned the news just past midnight in California, where he had been up late finishing a paper. His phone rang by his bedside, and he told reporters it took him about half a minute to find words. Then, he said, he got up to pack school lunches for his children. Nagel was on holiday in Italy, sitting in the sun on a terrace, and told the committee he had not expected the call at all, CNN reported. Friends of his watch the October announcements every year, he said, but he had assumed his work was still too new for the Nobel Medicine Prize. Thomas Perlmann, the committee's secretary, said he reached all three winners by phone on Monday.

The three laureates share a prize of 12 million Swedish crowns. The medicine award traditionally opens Nobel week, with the physics, chemistry, literature, peace and economics prizes announced over the coming days, through October 12. Last year's medicine prize went to Mary Brunkow, Fred Ramsdell and Shimon Sakaguchi for work on how the immune system spares healthy cells, research that, as Reuters reported, opened paths toward possible new cancer treatments. This year's winners of the Nobel Medicine Prize receive their awards at the ceremony in Stockholm on December 10.

The win puts a working tool, not a theory, on the biggest science stage of the year. Neuroscience labs already treat optogenetics as routine equipment, and the field it built is aimed at one of the hardest problems in medicine: fixing misfiring circuits instead of bathing the whole brain in drugs. Nagel noted that, so far, he knows of one patient who has benefited from an optogenetics-based treatment, which shows how wide the gap between laboratory and clinic still is. For anyone watching how brain research turns into real therapies, this year's Nobel Medicine Prize marks the method that made the brain's wiring diagram readable.